Delivery Order SPE2DB25D3109-SPE2DB25FPKKB
Award Date
5/8/25
Potential Completion Date
5/9/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,327.20 firm fixed-price contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 24, 2023 and was awarded on November 22, 2023. This delivery order is part...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,131.14, is for the supply of Quillivant XR oral suspension, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed-price pricing type and an ultimate completion date of March 3, 2025. AmerisourceBergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,974.70 firm fixed-price contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is not set-aside and has an ultimate completion date of May 1, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,037.64, is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a completion date of April 15, 2025 and is a firm fixed-price delivery order. This contract is part of a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed price of $1,051.36 and a period of performance through March 31, 2025. The contract was not set aside for any specific business category....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,226.86, is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used in the treatment of attention deficit hyperactivity disorder (ADHD). The contract has a firm fixed price pricing type and a completion date of May 9, 2024. This delivery order is part of a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,445.62, is for the delivery of Quillivant XR 25 mg/5 ml suspension, a medication used for the treatment of attention deficit hyperactivity disorder (ADHD). The contract is a Firm Fixed Price Delivery Order with a performance period through March 28, 2025. It is not designated as a set-aside...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,571.26 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of March 25, 2025 and was awarded on March 24, 2025. This delivery order is part of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Quillivant XR Oral Suspension, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has a ceiling value of $7,630.42 and is a firm fixed-price contract with an ultimate completion date of April 16, 2025. This contract is not a set-aside and was...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,595.17, is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract is a delivery order with a firm fixed price and has an ultimate completion date of November 5, 2024. The contract is not designated...